ERBB3 and cancer: With the advent of high throughput massively parallel sequencing technology of next generation sequencing, the first major study to explore the role of HER3 mutations in cancer was Jaiswal et al. in 2013, in which the frequent occurrence in colon and gastric cancers was studied [26].